Testosterone Gel in Poor Responders Undergoing IVF

Summary

The main purpose of this study is to compare the number of oocytes retrieved after using transdermal testosterone gel 10 mg per day or Dehydroepiandrosterone (DHEA) 75mg per day for 6-8 weeks as pre-treatment for poor ovarian responders undergoing in-vitro fertilization (IVF).

Timeline

Start

2015-09

Primary completion

2016-05

Completion

2016-08

Drugs

Indications